Skip to main content

Papaverine

Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer

  • RegistryNCT05136846
  • PhasePhase 1
  • StatusRecruiting
  • ConditionLocally Advanced Lung Non-Small Cell Carcinoma
  • SponsorOhio State University Comprehensive Cancer Center
How Papaverine worksNCT051368461 min

What the film says

Read the transcript

This trial is for stage 2 or 3 non small cell lung cancer that cannot be removed by surgery, in adults.

The idea: add papaverine to radiation. Papaverine targets mitochondrial metabolism, which is how cells make energy, and may work best given together with chemoradiation. It is given by vein or by injection under the skin, at rising doses.

The first question is the highest dose patients can tolerate. The trial plans 28 patients. At Ohio State University in Columbus, Jeremy Brownstein leads it.

Public record; not medical advice.

Sources behind this film

  • ClinicalTrials.gov record NCT05136846

    Stage 2 or 3 non small cell lung cancer that cannot be removed by surgery, adults; Papaverine targets mitochondrial metabolism (how cells make energy; plain-language gloss); May work best given together with chemoradiation; Given by vein or injection under the skin, at rising doses (+3 more lines)

The drug

What is being tested.

PRIMARY OBJECTIVE: I. To determine the maximally tolerated dose of papaverine (PPV) in combination with chemoradiation (CRT)/radiation therapy (RT) in patients with unresectable locally advanced (LA) non-small cell lung cancer (NSCLC) or oligometastatic NSCLC. SECONDARY OBJECTIVES: I. To estimate the rates of primary tumor control, local control, time to local-regional progression, disease-free survival (DFS), and overall survival (OS). II.

To assess whether blood oxygen level determination (BOLD) functional magnetic resonance imaging (MRI) studies can predict which patients may respond best to PPV + CRT/RT, and detect changes in oxygenation before and after PPV administration. III. To assess whether blood-based and tissue-based biomarkers can predict which patients may respond best to PPV + CRT. OUTLINE: This is a dose-escalation study of PPV.

The study

How the trial runs.

This phase I trial finds out the best dose, possible benefits and/or side effects of papaverine when given together with chemoradiation intreating patients with stage II-III non-small cell lung cancer. Papaverine targets mitochondrial metabolism to decrease the cancer growth process. Giving papaverine with chemoradiation may work best to treat patients with non-small cell lung cancer.

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • All prior treatment-related toxicities must be Common Terminology Criteria for Adverse Events (CTCAE) (version 5.0) =< grade 1 (except alopecia) at the time of enrollment
  • Absolute neutrophil count >=1.5 x 10^9/L
  • Hemoglobin >= 9 g/dL
  • Platelets >= 100 x 10^9/L
  • Total bilirubin =< 1.5 x upper limit of normal (ULN)
  • Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 2.5 x ULN

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.